Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality

Detalhes bibliográficos
Autor(a) principal: Lino,Katia
Data de Publicação: 2021
Outros Autores: Guimarães,Gabriel Macedo Costa, Alves,Lilian Santos, Oliveira,Any Caroline, Faustino,Renan, Fernandes,Cintia Souza, Tupinambá,Gleiser, Medeiros,Thalia, Silva,Andrea Alice da, Almeida,Jorge Reis
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207
Resumo: ABSTRACT Introduction: Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective: To study the association between ferritin levels at admission, representing an inflammatory state, and hospital mortality in COVID-19 patients. Methods: From May through July 2020, SARS-CoV-2 positive patients with moderate to severe clinical symptoms were evaluated at admission, regarding clinical and laboratory data on renal and hepatic function, hematologic parameters, cytomegalovirus co-infection, and acute phase proteins. Results: A total of 97 patients were included; mean age = 59.9 ± 16.3 years, 58.8% male, 57.7% non-white, in-hospital mortality = 45.4%. Age, ferritin, C-reactive protein, serum albumin and creatinine were significantly associated with mortality. Ferritin showed area under the curve (AUC) of 0.79 (p < 0.001) for the cut-off of 1873.0 ng/mL, sensitivity of 68.4% and specificity of 79.3% in predicting in-hospital mortality. Age ≥60 years had an odds ratio (OR) of 10.5 (95% CI = 1.8–59.5; p = 0.008) and ferritin ≥1873.0 ng/mL had an OR of 6.0 (95% CI = 1.4–26.2; p = 0.016), both independently associated with mortality based on logistic regression analysis. Conclusion: The magnitude of inflammation present at admission of COVID-19 patients, represented by high ferritin levels, is independently predictive of in-hospital mortality.
id BSID-1_0a20fe44cc8d7891a7574fdba721c57d
oai_identifier_str oai:scielo:S1413-86702021000200207
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortalitySARS-CoV-2FerritinMortalityCytokine stormHemophagocytic lymphohistiocytosisABSTRACT Introduction: Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective: To study the association between ferritin levels at admission, representing an inflammatory state, and hospital mortality in COVID-19 patients. Methods: From May through July 2020, SARS-CoV-2 positive patients with moderate to severe clinical symptoms were evaluated at admission, regarding clinical and laboratory data on renal and hepatic function, hematologic parameters, cytomegalovirus co-infection, and acute phase proteins. Results: A total of 97 patients were included; mean age = 59.9 ± 16.3 years, 58.8% male, 57.7% non-white, in-hospital mortality = 45.4%. Age, ferritin, C-reactive protein, serum albumin and creatinine were significantly associated with mortality. Ferritin showed area under the curve (AUC) of 0.79 (p < 0.001) for the cut-off of 1873.0 ng/mL, sensitivity of 68.4% and specificity of 79.3% in predicting in-hospital mortality. Age ≥60 years had an odds ratio (OR) of 10.5 (95% CI = 1.8–59.5; p = 0.008) and ferritin ≥1873.0 ng/mL had an OR of 6.0 (95% CI = 1.4–26.2; p = 0.016), both independently associated with mortality based on logistic regression analysis. Conclusion: The magnitude of inflammation present at admission of COVID-19 patients, represented by high ferritin levels, is independently predictive of in-hospital mortality.Brazilian Society of Infectious Diseases2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207Brazilian Journal of Infectious Diseases v.25 n.2 2021reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2021.101569info:eu-repo/semantics/openAccessLino,KatiaGuimarães,Gabriel Macedo CostaAlves,Lilian SantosOliveira,Any CarolineFaustino,RenanFernandes,Cintia SouzaTupinambá,GleiserMedeiros,ThaliaSilva,Andrea Alice daAlmeida,Jorge Reiseng2021-06-16T00:00:00Zoai:scielo:S1413-86702021000200207Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2021-06-16T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
title Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
spellingShingle Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
Lino,Katia
SARS-CoV-2
Ferritin
Mortality
Cytokine storm
Hemophagocytic lymphohistiocytosis
title_short Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
title_full Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
title_fullStr Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
title_full_unstemmed Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
title_sort Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
author Lino,Katia
author_facet Lino,Katia
Guimarães,Gabriel Macedo Costa
Alves,Lilian Santos
Oliveira,Any Caroline
Faustino,Renan
Fernandes,Cintia Souza
Tupinambá,Gleiser
Medeiros,Thalia
Silva,Andrea Alice da
Almeida,Jorge Reis
author_role author
author2 Guimarães,Gabriel Macedo Costa
Alves,Lilian Santos
Oliveira,Any Caroline
Faustino,Renan
Fernandes,Cintia Souza
Tupinambá,Gleiser
Medeiros,Thalia
Silva,Andrea Alice da
Almeida,Jorge Reis
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lino,Katia
Guimarães,Gabriel Macedo Costa
Alves,Lilian Santos
Oliveira,Any Caroline
Faustino,Renan
Fernandes,Cintia Souza
Tupinambá,Gleiser
Medeiros,Thalia
Silva,Andrea Alice da
Almeida,Jorge Reis
dc.subject.por.fl_str_mv SARS-CoV-2
Ferritin
Mortality
Cytokine storm
Hemophagocytic lymphohistiocytosis
topic SARS-CoV-2
Ferritin
Mortality
Cytokine storm
Hemophagocytic lymphohistiocytosis
description ABSTRACT Introduction: Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective: To study the association between ferritin levels at admission, representing an inflammatory state, and hospital mortality in COVID-19 patients. Methods: From May through July 2020, SARS-CoV-2 positive patients with moderate to severe clinical symptoms were evaluated at admission, regarding clinical and laboratory data on renal and hepatic function, hematologic parameters, cytomegalovirus co-infection, and acute phase proteins. Results: A total of 97 patients were included; mean age = 59.9 ± 16.3 years, 58.8% male, 57.7% non-white, in-hospital mortality = 45.4%. Age, ferritin, C-reactive protein, serum albumin and creatinine were significantly associated with mortality. Ferritin showed area under the curve (AUC) of 0.79 (p < 0.001) for the cut-off of 1873.0 ng/mL, sensitivity of 68.4% and specificity of 79.3% in predicting in-hospital mortality. Age ≥60 years had an odds ratio (OR) of 10.5 (95% CI = 1.8–59.5; p = 0.008) and ferritin ≥1873.0 ng/mL had an OR of 6.0 (95% CI = 1.4–26.2; p = 0.016), both independently associated with mortality based on logistic regression analysis. Conclusion: The magnitude of inflammation present at admission of COVID-19 patients, represented by high ferritin levels, is independently predictive of in-hospital mortality.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2021.101569
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.25 n.2 2021
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209245176266752